Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Plerixafor+G-CSF–mobilized CD34 + cells represent an optimal graft source for thalassemia gene therapy

Garyfalia Karponi, Nikoletta Psatha, Carsten Werner Lederer, Jennifer Eileen Adair, Fani Zervou, Nikolaos Zogas, Marina Kleanthous, Constantinos Tsatalas, Achilles Anagnostopoulos, Michel Sadelain, Isabelle Rivière, George Stamatoyannopoulos, Evangelia Yannaki

Blood (2015) 126 (5): 616–619.

https://doi.org/10.1182/blood-2015-03-629618

Published: 2015

Includes: Supplemental data

Journal Articles

Safe mobilization of CD34 + cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

Farid Boulad, Xiuyan Wang, Jinrong Qu, Clare Taylor, Leda Ferro, Garyfalia Karponi, Shirley Bartido, Patricia Giardina, Glenn Heller, Susan E. Prockop, Aurelio Maggio, Michel Sadelain, Isabelle Rivière

Blood (2014) 123 (10): 1483–1486.

https://doi.org/10.1182/blood-2013-06-507178

Published: 2014

Includes: Supplemental data

Journal Articles

The Ex-Vivo Tolerance Induction To TLR7 In Donor Lymphocytes Prevents aGvHD In a Mismatched Transplantation Mouse Model

Nikolaos Zogas, PhD student, Stylianos Malasidis, MSc, Fotios Iordanidis, MD, Garyfalia Karponi, PhD student, Eleftheria Tsolaki, PhD student, Zaharias Scouras, PhD, Achilles Anagnostopoulos, MD, Evangelia Yannaki, MD

Blood (2013) 122 (21): 4469.

https://doi.org/10.1182/blood.V122.21.4469.4469

Published: 2013

Journal Articles

Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor

Evangelia Yannaki, MD, Thalia Papayannopoulou, Erica Jonlin, PhD, Fani Zervou, Garyfalia Karponi, Angeliki Xagorari, PhD, Pamela S. Becker, MD, PhD, Nikoleta Psatha, Ioannis Batsis, MD, Panayotis Kaloyannidis, MD, Varvara Tahynopoulou, Varnavas Constantinou, Asimenia Bouinta, Konstantia Kotta, Aglaia Athanassiadou, PhD, Achilles Anagnostopoulos, Athanasios Fassas, MD, George Stamatoyannopoulos, MD, DSci

Blood (2011) 118 (21): 166.

https://doi.org/10.1182/blood.V118.21.166.166

Published: 2011

Journal Articles

Limitations of G-CSF Mobilization in Splenectomized Patients with Beta-Thalassemia Major: Implications for Thalassemia Gene Therapy.

Evangelia Yannaki, MD, Thalia Papayannopoulou, MD, Erica Jonlin, PhD, Ioannis Batsis, MD, Pamela S. Becker, MD, PhD, Fani Zervou, BS, Angeliki Xagorari, PhD, Garyfalia Karponi, BS, Varvara Tahynopoulou, BS, Panayotis Kaloyannidis, MD, Varnavas Constantinou, MD, Achilles Anagnostopoulos, MD, Athanasios Fassas, MD, George Stamatoyannopoulos, MD, DSci

Blood (2009) 114 (22): 2150.

https://doi.org/10.1182/blood.V114.22.2150.2150

Published: 2009

NARROW

Plerixafor+G-CSF–mobilized CD34 + cells represent an optimal graft source for thalassemia gene therapy

Safe mobilization of CD34 + cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

The Ex-Vivo Tolerance Induction To TLR7 In Donor Lymphocytes Prevents aGvHD In a Mismatched Transplantation Mouse Model

Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor

Limitations of G-CSF Mobilization in Splenectomized Patients with Beta-Thalassemia Major: Implications for Thalassemia Gene Therapy.

Email alerts

ASH Publications

American Society of Hematology

Plerixafor+G-CSF–mobilized CD34 + cells represent an optimal graft source for thalassemia gene therapy

Safe mobilization of CD34 + cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

The Ex-Vivo Tolerance Induction To TLR7 In Donor Lymphocytes Prevents aGvHD In a Mismatched Transplantation Mouse Model

Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor

Limitations of G-CSF Mobilization in Splenectomized Patients with Beta-Thalassemia Major: Implications for Thalassemia Gene Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only